Back to SPPI Stock Lookup

Spectrum Pharma (SPPI) – Company Press Releases

Jan 29, 2016 07:00 AM Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Jan 11, 2016 07:00 AM Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada
Dec 16, 2015 07:00 AM Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Dec 15, 2015 01:23 PM TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers
Dec 10, 2015 08:30 AM Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform
Dec 9, 2015 07:40 PM INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Urges Investors to Contact the Firm
Dec 8, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Four Abstracts on SPI-2012 and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS)
Dec 6, 2015 12:00 PM Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat (Beleodaq®) and Standard CHOP
Dec 4, 2015 07:00 AM Spectrum Pharmaceuticals Highlights 18 Abstracts at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, December 5-8, 2015
Nov 20, 2015 07:00 AM Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib
Nov 18, 2015 03:00 AM Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma
Nov 17, 2015 12:11 PM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 12, 2015 10:25 PM DEADLINE ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm
Nov 10, 2015 08:14 PM Lifshitz & Miller Law Firm Announces Investigation of Applied DNA Sciences Inc., Barrett Business Services Inc., First Niagara Financial Group, Fidelity & Guaranty Life, SORL Auto Parts, Inc.,
Nov 4, 2015 07:33 PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Strongly Encourages Shareholders to Contact the Firm
Nov 4, 2015 04:02 PM Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement
Nov 4, 2015 04:01 PM Spectrum Pharmaceuticals Reports Third Quarter 2015 Financial Results and Pipeline Update
Nov 4, 2015 10:52 AM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 2, 2015 07:00 AM Spectrum Pharmaceuticals Announces Third Quarter 2015 Financial Results Teleconference and Webcast
Oct 29, 2015 08:53 PM INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Spectrum Pharmaceuticals, Inc. and Advises Investors to Contact the Firm
Oct 26, 2015 07:00 AM Spectrum Pharmaceuticals Initiates Apaziquone Pivotal Trial for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) Following SPA Agreement
Oct 23, 2015 05:27 PM INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Oct 23, 2015 12:30 AM Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA™ (melphalan) for Injection
Sep 3, 2015 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw 17th Annual Global Investment Conference on September 10th
Sep 2, 2015 07:00 AM Spectrum Pharmaceuticals Announces Publication of Pivotal EVOMELA™ (melphalan hydrochloride) for Injection Data in the Biology of Blood and Marrow Transplantation Journal
Aug 17, 2015 07:00 AM Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Upcoming Apaziquone Phase 3 Trial in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)
Aug 6, 2015 04:00 PM Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update
Jul 30, 2015 07:00 AM Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 24, 2015 07:00 AM Spectrum Pharmaceuticals Announces Publication of Beleodaq® Data Selected as a Rapid Communication in the Journal of Clinical Oncology
May 29, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Five Abstracts of Clinical Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29-June 2, 2015
May 28, 2015 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
May 14, 2015 07:00 AM Spectrum Pharmaceuticals Commits to Review Shareholder Proposal
May 7, 2015 04:00 PM Spectrum Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results
Apr 30, 2015 07:00 AM Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast
Mar 30, 2015 07:00 AM Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability
Mar 13, 2015 07:00 AM Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results
Mar 11, 2015 07:00 AM Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals’ Analyst Day on Friday, March 13th
Mar 9, 2015 07:00 AM Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan

Back to SPPI Stock Lookup